Literature DB >> 23442164

Trends in fentanyl prescriptions and fentanyl-related mortality in Australia.

Amanda Roxburgh1, Lucy Burns, Olaf H Drummer, Jennifer Pilgrim, Michael Farrell, Louisa Degenhardt.   

Abstract

INTRODUCTION AND AIMS: The study aims to quantify trends in fentanyl prescribing and fentanyl mortality in Australia within the context of concern among health professionals concerning increasing accessibility of fentanyl, and the harms that may arise as a result. DESIGN AND METHODS: This paper presents data on prescribing patterns of fentanyl by 10 year age group adjusted by population rate, detailed analyses of fentanyl-related deaths from the National Coronial Information System and deaths adjusted for prescribing levels within Australia.
RESULTS: Fentany prescriptions have increased and are most prevalent among Australians aged over 80 years. One hundred and thirty-six fentanyl-related deaths were recorded during 2000-2011; 54% of decedents had a history of injecting drug use and, among this group, 95% had injected fentanyl at the time of death; 62% of deaths recorded misuse (most notably injection) of fentanyl; 50% recorded a history of drug dependence and 40% a mental health problem; 37% recorded a history of chronic pain; and 36% recorded fentanyl as being prescribed at the time of death. Deaths were primarily among Australians under 47 years of age. DISCUSSION AND
CONCLUSIONS: There have been significant increases in fentanyl prescribing in Australia. It is unclear what proportion of this increase represents legitimate treatment of pain. Fentanyl deaths have also increased, although mortality is currently low in Australia. A large proportion of the deaths involved the injection of diverted fentanyl, highlighting the need for messages regarding safer injecting practices targeting people who inject drugs, and strategies to minimise the risks of diversion.
© 2013 Australasian Professional Society on Alcohol and other Drugs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23442164     DOI: 10.1111/dar.12033

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  16 in total

1.  Illicit fentanyls in the opioid street market: desired or imposed?

Authors:  Sarah G Mars; Daniel Rosenblum; Daniel Ciccarone
Journal:  Addiction       Date:  2018-12-04       Impact factor: 6.526

2.  Sensitivity and specificity of administrative mortality data for identifying prescription opioid-related deaths.

Authors:  Emilie Gladstone; Kate Smolina; Steven G Morgan; Kimberly A Fernandes; Diana Martins; Tara Gomes
Journal:  CMAJ       Date:  2015-11-30       Impact factor: 8.262

3.  Duration of opioid use and association with socioeconomic status, daily dose and formulation: a two-decade population study in Queensland, Australia.

Authors:  Adeleke D Adewumi; Joemer C Maravilla; Rosa Alati; Samantha A Hollingworth; Xuelei Hu; Bill Loveday; Jason P Connor
Journal:  Int J Clin Pharm       Date:  2020-06-16

4.  Fentanyl in the US heroin supply: A rapidly changing risk environment.

Authors:  Daniel Ciccarone
Journal:  Int J Drug Policy       Date:  2017-07-20

5.  The relative lethal toxicity of pharmaceutical and illicit substances: A 16-year study of the Greater Newcastle Hunter Area, Australia.

Authors:  Jonathan Brett; Claire E Wylie; Jacques Raubenheimer; Geoff K Isbister; Nick A Buckley
Journal:  Br J Clin Pharmacol       Date:  2019-07-17       Impact factor: 4.335

6.  U.S. prescribing trends of fentanyl, opioids, and other pain medications in outpatient and emergency department visits from 2006 to 2015.

Authors:  Aishwarya Vijay; Taeho Greg Rhee; Joseph S Ross
Journal:  Prev Med       Date:  2019-03-17       Impact factor: 4.018

7.  An update on oxycodone: lessons for death investigators in Australia.

Authors:  Jennifer L Pilgrim; Sabrina Putrianita Yafistham; Sanjeev Gaya; Eva Saar; Olaf H Drummer
Journal:  Forensic Sci Med Pathol       Date:  2014-11-18       Impact factor: 2.007

Review 8.  An overview of the patterns of prescription opioid use, costs and related harms in Australia.

Authors:  Bianca Blanch; Sallie-Anne Pearson; Paul S Haber
Journal:  Br J Clin Pharmacol       Date:  2014-11       Impact factor: 4.335

9.  Predictors of persistent prescription opioid analgesic use among people without cancer in Australia.

Authors:  Samanta Lalic; Natasa Gisev; J Simon Bell; Maarit Jaana Korhonen; Jenni Ilomäki
Journal:  Br J Clin Pharmacol       Date:  2018-04-02       Impact factor: 4.335

10.  Twenty-five years of prescription opioid use in Australia: a whole-of-population analysis using pharmaceutical claims.

Authors:  Emily A Karanges; Bianca Blanch; Nicholas A Buckley; Sallie-Anne Pearson
Journal:  Br J Clin Pharmacol       Date:  2016-05-07       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.